Team:UC Chile/Accomplishments
From 2012.igem.org
(Difference between revisions)
(Created page with "{{UC_Chile4}} == Accomplishments == == Judging Criteria == We believe our team deserves the following medal: ☐Bronze ☐Silver ☐Gold Because we met the following criteri...") |
Juan Alamos (Talk | contribs) (→Judging Criteria) |
||
Line 16: | Line 16: | ||
<br>☐ Present a poster and a talk at the iGEM Jamboree | <br>☐ Present a poster and a talk at the iGEM Jamboree | ||
<br>✓ At least one new submitted and well-characterized standard BioBrick Part or Device. A new application of and outstanding documentation (quantitative data showing the Part’s/ Device’s function) of a previously existing BioBrick part in the “Experience” section of that BioBrick’s Registry entry also counts. | <br>✓ At least one new submitted and well-characterized standard BioBrick Part or Device. A new application of and outstanding documentation (quantitative data showing the Part’s/ Device’s function) of a previously existing BioBrick part in the “Experience” section of that BioBrick’s Registry entry also counts. | ||
+ | |||
+ | ''We submitted parts [http://partsregistry.org/Part:BBa_K743000 BBa_K743000] and [http://partsregistry.org/Part:BBa_K743001 BBa_K743001] wich were verified by digestion and sequencing. The functioning of these parts was extensively proved by our succesfull transformation of synechocystis, what is well documented in our [https://2012.igem.org/Team:UC_Chile/Cyanolux/Results results]. | ||
+ | We also characterized the functioning of KanR resistance genes [http://partsregistry.org/Part:BBa_P1003 P1003] and [http://partsregistry.org/Part:BBa_P1007 P1007] in Synechocystis PCC6803. | ||
+ | Lastly, we quantitatively characterized the [http://partsregistry.org/Part:BBa_K325909 Luxbrick] in different temperature, o.d, glucose concentration and growth fase conditions.'' | ||
<big> Silver: </big> In addition to the Bronze Medal requirements...<br> | <big> Silver: </big> In addition to the Bronze Medal requirements...<br> | ||
- | [[File:UC_Chile-silver.jpg|left|50 px]]<br> | + | [[File:UC_Chile-silver.jpg|left|50 px]]<br>✓ Demonstrate that at least one new BioBrick Part or Device of your own design and construction works as expected |
- | + | ''Parts [http://partsregistry.org/Part:BBa_K743000 BBa_K743000] and [http://partsregistry.org/Part:BBa_K743001 BBa_K743001] worked as expected in Synechocystis double homologous recombination transformations.'' | |
+ | ''Part [http://partsregistry.org/Part:BBa_K743017 BBa_K743017] showed inducible expression as planned. | ||
+ | Device [http://partsregistry.org/Part:BBa_K743006 BBa_K743006] showed the right results, i.e was usefull for transformation and selection in Synechocystis.'' | ||
+ | <br>✓Characterize the operation of at least one new BioBrick Part or Device and enter this information in the “Main Page” section of that Part’s/Device’s Registry entry | ||
+ | ''Device [http://partsregistry.org/Part:BBa_K743006 BBa_K743006] undergoes double homologous recombination in Synechocystis PCC6803 and conferes kanamycin resistance. Other sequences can be added to it and its effectiveness remains as shown in [http://partsregistry.org/Part:BBa_K743005 BBa_K743005] | ||
+ | '' | ||
Line 28: | Line 37: | ||
[[File:UC_Chile-Gold.jpg|left|50 px]]☐ Improve the function of an existing BioBrick Part or Device (created by another team or your own institution in a previous year) and enter this information in the Registry (in the “Experience” section of that BioBrick’s Registry entry), and don't forget to create a new registry page for the improved part. | [[File:UC_Chile-Gold.jpg|left|50 px]]☐ Improve the function of an existing BioBrick Part or Device (created by another team or your own institution in a previous year) and enter this information in the Registry (in the “Experience” section of that BioBrick’s Registry entry), and don't forget to create a new registry page for the improved part. | ||
☐ Help another iGEM team by, for example, characterizing a part, debugging a construct, or modeling or simulating their system. | ☐ Help another iGEM team by, for example, characterizing a part, debugging a construct, or modeling or simulating their system. | ||
- | <br> | + | <br>✓Outline and detail a new approach to an issue of Human Practice in synthetic biology as it relates to your project, such as safety, security, ethics, or ownership, sharing, and innovation. |
- | + | We proposed a new and simple biosafety strategy designed to be easily adopted in all biobricks. It will need minimal imputs. For more information please check our [https://2012.igem.org/Team:UC_Chile/Biosafety biosafety] section. | |
+ | On the other hand, we organized a Synthetic Biology workshop | ||
{{UC_Chilefooter}} | {{UC_Chilefooter}} |
Revision as of 05:30, 26 September 2012